We have previously demonstrated that c-MET/HGF pathway not only is functional in SCLC, it also harbours novel mutations of c-MET in the semaphorin and juxtamembrane domains (Maulik et al, 2002a; Kijima et al, 2003; Ma et al, 2003a). Here, MET is linked to small cell lung carcinoma.